Liver Cancer in the Middle East

dc.authorscopusid57217614267
dc.contributor.authorCarr B.I.
dc.date.accessioned2024-08-04T20:03:49Z
dc.date.available2024-08-04T20:03:49Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThis book aims to illuminate the causes, incidence, and treatments of Hepatocellular Carcinoma(HCC) or liver cancer in the politically important and societally diverse region of the Middle East. Taking a flexible and inclusive view, it examines the influences of geography, crops and diet, ethnicity, and local behavior on both diagnosis and outcomes of this disease. Understanding the different causes of liver cancer enables effective strategies for both prevention and early diagnosis while knowledge of the different treatment modalities, their uses and limitations, availability and costs, works to inform rational treatment provision and selection. Divided into four sections, this book considers the causes and clinical syndromes associated with HCC, provides a detailed overview of clinical HCC and treatment modalities, describes country-specific clinical HCC experience and practice, and considers future needs and the potential for HCC collaborations across the region. Liver Cancer in the Middle East is a useful resource for clinicians seeking insight into the second highest cause of death from cancer worldwide, governments planning social and medical services for their peoples, as well as for international aid agencies prioritizing donations. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021. All rights reserved.en_US
dc.identifier.doi10.1007/978-3-030-78737-0
dc.identifier.endpage414en_US
dc.identifier.isbn9783030787370
dc.identifier.isbn9783030787363
dc.identifier.scopus2-s2.0-85159722409en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage1en_US
dc.identifier.urihttps://doi.org/10.1007/978-3-030-78737-0
dc.identifier.urihttps://hdl.handle.net/11616/92130
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringer International Publishingen_US
dc.relation.ispartofLiver Cancer in the Middle Easten_US
dc.relation.publicationcategoryKitap - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAflatoxinen_US
dc.subjectChemo-Embolizationen_US
dc.subjectClinical Signs and Symptomsen_US
dc.subjectHBVen_US
dc.subjectHCC Phenotypingen_US
dc.subjectHCVen_US
dc.subjectImmune-Modulation Therapiesen_US
dc.subjectMolecular Targeted Therapiesen_US
dc.subjectRadio-Embolizationen_US
dc.titleLiver Cancer in the Middle Easten_US
dc.typeBooken_US

Dosyalar